Jeff Liter

Jeff Liter is a seasoned executive with a diverse background in the biotechnology, consulting, and telecommunications industries.

He holds a Master of Business Administration in Finance from the University of Minnesota - Carlson School of Management, complemented by a Bachelor of Science in Business from Illinois State University.

With a solid educational foundation that includes studies at Washington High School and additional MBA studies at The Carlson School of Management, Jeff has been well-equipped for his various leadership roles.

Currently serving as the President and Chief Executive Officer at Luminary Therapeutics, Inc., Jeff has a track record of driving growth and innovation at the helm of organizations.

Prior to his current role, Jeff held the position of Chief Executive Officer at Ox2 Therapeutics and also led B-Mogen Biotechnologies, Inc. as its President and Chief Executive Officer.

His professional journey includes roles such as Senior Principal at West Monroe, Chief Operating Officer at Hitachi Chemical Advanced Therapeutics Solutions, Llc, and Director of Strategy, Business Development, and Licensing at Beckman Coulter.

Jeff has also contributed his expertise as the Managing Director at On Point Consulting, Vice President of Sales and Vice President of EMEA Channel Sales at Adc Telecommunications, as well as Vice President of Corporate Business Development at Adc.

His experience encompasses diverse leadership positions, including Director of Corporate Development at Adc Telecommunications, Chief Financial Officer at Midwest Systems, Director of Operations NCR Credit Corp at Ncr Corporation, and Vice President of Finance, Chief Financial Officer at Centron.

With a comprehensive career spanning various sectors and leadership capacities, Jeff Liter brings a wealth of experience and strategic acumen to the organizations he serves, driving business success and fostering growth.